Skip to content

Evaluation of Efficacy and safety of steaming therapy and polyherbal formulation in the management of fibromyalgia

Evaluation of Efficacy and Safety of Inkibab i Shabat (Steaming of Anethum graveolens) and Habbe Gule Aak in the Management of Fibromyalgia An Open Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092896
Enrollment
44
Registered
2025-08-12
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M629- Disorder of muscle, unspecified

Interventions

Intervention1: Inkebab: The procedure of Inkibab to the test group will be carried out in Therapy Unit of Hakim Syed Zia ulHasan govternment Unani Hospital, Bhopal. The procedure will start as 50 gram

Sponsors

Hakim Syed Ziaul Hasan Government Unani Medical Collegeand Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age group between 18 to 60,All Genders, Chronic pain complaint above 3 months ,Patient of fibromyalgia having no surgical indication, Patient having no malignancy, VAS pain score more than or equal to 6 in the two previous weeks, formal consent to study participation, Able to speak, read and understand english or hindi, Patient fulfilling the inclusion criteria and agree to follow the protocol.

Exclusion criteria

Exclusion criteria: Patient with current diagnosis of infection or musculoskeletal inflammatory conditions, Use of NSAIDs ,opioids, anti depressants, betablockers in the 7 days before enrollment ,Chronic or acute pulmonary hematologic and kidney diseases, patient with confirm diagnosis of adrenal dysfunction , anemia, bone marrow disease, chronic fatigue syndrome, functional disorders, thyroid disorders, hypertension, diabetes mellitus, Lyme disease, multiple sclerosis, rheumatoid autoimmune disorders, spinal facet pain, vitamin and mineral deficiency, Patients with Active malignancy, Participation to other experimental studies in the month prior to the enrollment, Patients with Severe heart conditions or pacemaker, Chronic abuse of illicit drug and alcohol, Patients with Active Neuropsychiatric disorders, Females on oral contraceptive pills, Females in Menopausal Transition, Patient with permanent deformity, Patient having muscular contracture, Physiological state as pregnancy and lactation, Patients with history of trauma, Unwillingness or inability to comply the requirement of the protocol.

Design outcomes

Primary

MeasureTime frame
1.VAS (visual analogue scale) 2.WPI (widespread pain index) 3.SSI (symptoms severity) index) 4.FIQR (revised fibromyalgia impacted questionnaire) Timepoint: On day 0,7,14,21,28 and 35

Secondary

MeasureTime frame
SF12(Quality of life)Timepoint: On day 0,7,14,21,28 and 35

Countries

India

Contacts

Public ContactTazeen Naved

Hakim Syed Ziaul Hasan Government Unani Medical and Hospital

ehsan.azmi@gmail.com7354898786

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026